4.7 Article

Novel Stenotrophomonas maltophilia Bacteriophage as Potential Therapeutic Agent

Related references

Note: Only part of the references are listed.
Article Immunology

Emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan

Rui-Xin Wu et al.

Summary: The emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia (LTSRSM) in Taiwan is becoming a serious problem, but clinical data analysis on this has not been reported. A matched case-control-control study was conducted to investigate risk factors for LTSRSM occurrence in hospitalized patients.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2022)

Article Virology

Novel Bacteriophage Specific against Staphylococcus epidermidis and with Antibiofilm Activity

Rima Fanaei Pirlar et al.

Summary: Staphylococcus epidermidis is a major pathogen in infections related to medical devices, and its antibiotic resistance and biofilm formation make it difficult to treat. A new bacteriophage, CUB-EPI_14, has been isolated and shown to have potent antimicrobial and antibiofilm activities against S. epidermidis, offering new therapeutic opportunities.

VIRUSES-BASEL (2022)

Review Infectious Diseases

Benefits of Combined Phage-Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review

Kevin Diallo et al.

Summary: With the rise in bacterial resistance to antibiotics, the number of therapeutic failures is increasing globally. The high cost of developing new molecules has led to a broken antibiotic market. Combined phage-antibiotic therapy, a century-old method, offers a promising solution by enhancing the activity of existing antibiotics against specific bacteria through prolonging or restoring their effectiveness.

ANTIBIOTICS-BASEL (2022)

Review Chemistry, Medicinal

Manufacturing Bacteriophages (Part 2 of 2): Formulation, Analytics and Quality Control Considerations

Carolina Moraes de Souza et al.

Summary: This section discusses the process of manufacturing drug products from bacteriophage drug substances, emphasizing the various tradeoffs that need to be made in pharmaceutical development. It also introduces some historical and current analytical methods to consider when formulating bacteriophage products.

PHARMACEUTICALS (2021)

Article Microbiology

Cefiderocol Retains Antibiofilm Activity in Multidrug-Resistant Gram-Negative Pathogens

Christine A. Pybus et al.

Summary: The study compared the antimicrobial activity of Cefiderocol with seven commonly used antibiotics against multidrug-resistant pathogens, finding that Cefiderocol had potent inhibitory effects on biofilms of various pathogens, with consistently lower MIC90 values compared to other antibiotics.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Article Genetics & Heredity

Biological characteristics and genomic analysis of a Stenotrophomonas maltophilia phage vB_SmaS_BUCT548

Wenjing Zhang et al.

Summary: S. maltophilia has become an important opportunistic pathogen. The isolated phage vB_SmaS_BUCT548 from sewage of Beijing 307 Hospital exhibits a wide host range and strong lytic ability against multiple S. maltophilia strains. Next-Generation Sequencing reveals the genomic sequence specificity, providing insights for further exploration of the interaction mechanism between the phage and the host.

VIRUS GENES (2021)

Review Pharmacology & Pharmacy

The Burden of the Serious and Difficult-to-Treat Infections and a New Antibiotic Available: Cefiderocol

Yasaman Taheri et al.

Summary: This study summarized the pharmacological properties of cefiderocol, focusing on its therapeutic efficacy, safety, and tolerability in treating Gram-negative bacterial infections. The results indicated that cefiderocol may provide clinical benefit in treating severe infections caused by Gram-negative aerobic microorganisms in adult patients with limited treatment options.

FRONTIERS IN PHARMACOLOGY (2021)

Review Infectious Diseases

Antimicrobial Treatment Strategies for Stenotrophomonas maltophilia: A Focus on Novel Therapies

Jean Gibb et al.

Summary: Stenotrophomonas maltophilia is a urgent global threat due to its increasing incidence and intrinsic antibiotic resistance, but approved antibiotics in recent years have limited activity for it. Novel treatment strategies for Stenotrophomonas are desperately needed. Recommendations based on current evidence for a treatment strategy of Stenotrophomonas infection are offered after a systemic literature review.

ANTIBIOTICS-BASEL (2021)

Review Virology

The Potential of Phage Therapy against the Emerging Opportunistic Pathogen Stenotrophomonas maltophilia

Jaclyn G. McCutcheon et al.

Summary: The isolation and characterization of bacteriophages for treating infections caused by multidrug resistant Stenotrophomonas maltophilia is crucial. Research has focused on isolating new phages from the environment or induced from bacterial strains. Clinical significance, virulence factors, and antimicrobial resistance mechanisms of S. maltophilia have been summarized, along with strategies for using phages as an alternative treatment option. Limited in vivo phage therapy studies have been conducted, highlighting the need for future research in this area.

VIRUSES-BASEL (2021)

Review Biochemistry & Molecular Biology

A combination therapy of Phages and Antibiotics: Two is better than one

Xianghui Li et al.

Summary: The emergence of antibiotic resistance is a major challenge for global health, leading to an urgent need for alternative therapeutic strategies due to a shortage of antibiotic pipelines. Phage-antibiotic synergy (PAS) has emerged as a promising approach to combat antibiotic-resistant pathogens, by enhancing bacterial killing and reducing the development of antibiotic resistance through a combination of phages and antibiotics. Additionally, the genetic and molecular mechanisms of phage antibiotic synergy, as well as the potential of engineered phages in reducing bacterial pathogenicity, are addressed in this review.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Article Biochemistry & Molecular Biology

Structural Analysis of Jumbo Coliphage phAPEC6

Jeroen Wagemans et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Infectious Diseases

How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections

Majid Taati Moghadam et al.

INFECTION AND DRUG RESISTANCE (2020)

Article Multidisciplinary Sciences

The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia

Matthias I. Groeschel et al.

NATURE COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

Isolation and Characterization of the Novel Bacteriophage AXL3 againstStenotrophomonas maltophilia

Jaclyn G. McCutcheon et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Microbiology

Effect of bacterial growth rate on bacteriophage population growth rate

Dominik Nabergoj et al.

MICROBIOLOGYOPEN (2018)

Article Biochemistry & Molecular Biology

HMMER web server: 2018 update

Simon C. Potter et al.

NUCLEIC ACIDS RESEARCH (2018)

Article Multidisciplinary Sciences

Isolation, characterization and in vivo efficacy of Escherichia phage myPSH1131

Prasanth Manohar et al.

PLOS ONE (2018)

Article Biochemistry & Molecular Biology

Improvements to PATRIC, the all-bacterial Bioinformatics Database and Analysis Resource Center

Alice R. Wattam et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Biochemical Research Methods

Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads

Ryan R. Wick et al.

PLOS COMPUTATIONAL BIOLOGY (2017)

Article Biochemical Research Methods

ViPTree: the viral proteomic tree server

Yosuke Nishimura et al.

BIOINFORMATICS (2017)

Article Biotechnology & Applied Microbiology

Software-based analysis of bacteriophage genomes, physical ends, and packaging strategies

Bryan D. Merrill et al.

BMC GENOMICS (2016)

Article Biochemical Research Methods

The Phyre2 web portal for protein modeling, prediction and analysis

Lawrence A. Kelley et al.

NATURE PROTOCOLS (2015)

Article Multidisciplinary Sciences

Subdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters

Jeremy J. Barr et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Review Microbiology

Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen

Joanna S. Brooke

CLINICAL MICROBIOLOGY REVIEWS (2012)

Article Biochemical Research Methods

Easyfig: a genome comparison visualizer

Mitchell J. Sullivan et al.

BIOINFORMATICS (2011)

Article Biotechnology & Applied Microbiology

Isolation and characterization of lytic bacteriophages against enterohaemorrhagic Escherichia coli

S. Viazis et al.

JOURNAL OF APPLIED MICROBIOLOGY (2011)

Review Microbiology

The versatility and adaptation of bacteria from the genus Stenotrophomonas

Robert P. Ryan et al.

NATURE REVIEWS MICROBIOLOGY (2009)

Article Genetics & Heredity

Bacteriophage adsorption rate and optimal lysis time

Yongping Shao et al.

GENETICS (2008)